Abiopharma

🔍 Giacobbe Ken (Director)

Company: CARPENTER TECHNOLOGY CORP (CRS)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 225 shares of Director Stock Units (Derivative)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 225.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2, F2
• Acquired 21 shares of Director Stock Option (Right to Buy) at $537.57 per share (Derivative)
  Date: 2026-08-11 | Code: A | Expires: 2036-08-11 | Exercise: 2027-08-11 | equity_swap_involved: 0 | shares_owned_after: 21.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Converts to common stock on a 1-for-1 basis
• F2: Payable upon the later of separation of service or a specified date or event.
• F3: The reporting person was granted restricted stock units under the Carpenter Technology Corporation Stock-Based Compensation Plan for Non-Employee Directors.
• F4: The reporting person was granted an option to purchase stock under the Carpenter Technology Corporation Stock Based Compensation Plan for Non-Employee Directors.